Company intelligence / Profile preview

Laboratoires Techni-Pharma

Ownership: Private
Development stage: Commercial

Overview

Techni-Pharma manufactures nearly 45 million units of medication for human use, with some products among the top five or top ten best-sellers in France. They also produce cosmetic products and food supplements[5].

Therapeutic areas: OncologyGastroenterologyOther
Modalities: Small molecules
Industry: Biotech

Drug pipeline

5 assets

EDUCTYL

Commercial

Indications: Constipation

4 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Laboratoires Techni-Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Laboratoires Techni-Pharma.

Explore the full profile